Yangling Jinhai Biotechnology Co., Ltd.

Home About us Product Services News Contact

ABOUT US

Yangling Jinhai Biotechnology Co., Ltd. (hereinafter referred to as “Yangling Jinhai”) is approved by the Ministry of Agriculture, and is supported by Shanghai Haili Biotechnology Co., Ltd. (hereinafter referred to as “Haili Bio”) and Argentina Biogénesis Bagó SA (hereinafter referred to as “BAGO Company”. ") ....

PRODUCT CENTER

Trivalent Inactivated Vaccine of Type O, Type A and Type Asia1of FMDV (OHM/O2+AKT-Ⅲ+Asia1KZ/03)

Swine Bivalent Inactivated Vaccine of Type O and Type A of FMDV (OHM/02+AKT-III)

Swine Inactivated Vaccine of Type O of FMDV (O/Mya98/XJ/2010+O/GX/09-7)

Bivalent Inactivated Vaccine of Type O and Type A of FMDV (OHM/02+AKT-III)

NEWS

Jinhai webinar shared the key points to choose the right FMD vaccine

A webinar of topic How to choose a vaccine to prevent FMD in the autumn season was held by Jinhai on 8th Sep. Dr. Juan Rodriguez Persico presented the highly standardized manufacturing process, stabilization, safety, high potency, and cross-protection of Jinhai O+A FMD vaccine. The audience responded enthusiastically that night, attracting nearly 150,000 people to watch.

Biogenesis Bago awarded a contract with the United States Department of Agriculture to supply FMD vaccine bank to protect American livestock

The contract signed by Biogenesis Bago, a biotechnology company with presence in 25 countries in the Americas, Asia and Europe and worldwide leader in the fight versus Foot and Mouth Disease is for 17 years long.

The G20 First Agricultural Entrepreneurs Forum was held in Xi'an

(ReporterMaChao)Today(June2),thefirstG20GroupofAgriculturalEntrepreneursForumwassuccessfullyheldinXi'an.MinisterofAgricultureHanChangfuattendedtheopeningceremonyanddeliveredakeynotespeech.ShaanxiProvi